Cancer Biopsy Market - Global Industry Analysis

Cancer Biopsy Market - By Product (Kits & Consumables and Instruments), By Type (Tissue Biopsies and Liquid Biopsies), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 28-Jul-2021 Category: Healthcare Report Format : PDF Pages: 150 Report Code: ZMR-6534 Status : Published

The global cancer biopsy market accrued earnings worth approximately 22.3(USD Billion) in 2020 and is predicted to gain revenue of about 47.5(USD Billion) by 2028, is set to record a CAGR of nearly 11.1% over the period from 2021 to 2028.

Description

The global cancer biopsy market accrued earnings worth approximately 22.3(USD Billion) in 2020 and is predicted to gain revenue of about 47.5(USD Billion) by 2028, is set to record a CAGR of nearly 11.1% over the period from 2021 to 2028. The report offers assessment and analysis of the cancer biopsy market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Cancer Biopsy Market: Overview

A biopsy is the most commonly utilized clinical tests in which tissue samples are gathered and examined for determining whether the lump of cell tissues are hazardous or not. In cancer biopsy, physician removes small sample of tissues from easily accessible parts of human body or internal body parts and sends it to lab for examining them under microscope. Furthermore, tissue samples are also removed in outpatient settings for determining whether the tissues are cancer cells or not. In addition to this, common cancer biopsies include cervical, breast, skin, and prostate gland biopsies. In addition to this, sample of tissues can be derived from stomach, liver, muscles, and thyroid.

Moreover, when physician feels something unusual at time of physical examining of patient, the doctor can perform biopsy. Apparently, biopsies can be necessary for clarifying whether imaging methods like x-rays & ultrasound techniques demonstrate abnormal tissue areas.

Global Cancer Biopsy Market

Cancer Biopsy Market: Growth Drivers

Massive application of liquid biopsy and breakthroughs in biopsy methods are slated to steer expansion of cancer biopsy market over forthcoming years. In addition to this, minimal invasive nature of deriving circulating tumor cells has made biopsy as most popular tool in detecting various kinds of cancer in patients. Apparently, introduction of new techniques such as next-generation sequencing will embellish industry space in upcoming years. Furthermore, a prominent role played by image-driven needle biopsies in domain of precision medicine will proliferate size of cancer biopsy market over ensuing years.

Moreover, surging molecular assays is key to expansion of cancer biopsy industry. Additionally, in clinical studies, biopsies are also utilized for identifying drug response rate for patients receiving epidermal growth factor receptor treatments. This will further drive market trends. Apart from this, increase in number of medical trials in biomarker research activities will expand cancer biopsy market size.

Regional Landscape

North America To Make Notable Contributions Towards Overall Market Size By 2028

The expansion of cancer biopsy industry in North America during assessment period is owing to prominent surge in number of diagnostic kit manufacturers & distributors in the sub-continent. Rise in acceptance of liquid biopsies in the U.S. will create lucrative growth avenues for cancer biopsy industry in North America during assessment period.

Competitive Landscape

Key players profiled in report and leveraging market growth are Qiagen N.V., Hologic, Inc., Illumina, Inc., Biocept, Inc., ANGLE Plc,  Danaher Corporation, Roche Holding AG, GRAIL, Inc., Freenome Holdings, Inc., Lucence Diagnostics Private Limited, Epigenomics AG, HelioHealth, Genesystems, Inc., Natera, Inc., Chronix Biomedical , Inc., Personal Genome Diagnostics Inc., Personalis Inc., and Biodesix.

The global Cancer Biopsy Market is segmented as follows:

By Product

  • Kits & Consumables
  • Instruments

By Type

  • Tissue Biopsies
  • Liquid Biopsies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Cancer Biopsy Market, 2018–2028(USD Billion)
    • 2.2. Cancer Biopsy Market: Snapshot
  • Chapter 3. Global Cancer Biopsy Market– Type Analysis
    • 3.1. Cancer Biopsy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Massive application of liquid biopsy and breakthroughs in biopsy methods are set to spur growth of cancer biopsy market in upcoming years.
      • 3.2.2. Launching of new methods like next-generation sequencing will embellish industry size within next few years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Product
      • 3.4.2. Market attractiveness analysis By Type
  • Chapter 4. Global Cancer Biopsy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Cancer Biopsy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Cancer Biopsy Market– Product Analysis
    • 5.1. Global Cancer Biopsy Market overview: By Product
      • 5.1.1. Global Cancer Biopsy Market share, By Product, 2020 and 2028
    • 5.2. Kits & Consumables
      • 5.2.1. Global Cancer Biopsy Market by Kits & Consumables, 2018–2028(USD Billion)
    • 5.3. Instruments
      • 5.3.1. Global Cancer Biopsy Market by Instruments, 2018–2028(USD Billion)
  • Chapter 6. Global Cancer Biopsy Market– Type Analysis
    • 6.1. Global Cancer Biopsy Market overview: By Type
      • 6.1.1. Global Cancer Biopsy Market share, By Type, 2020 and 2028
    • 6.2. Tissue Biopsies
      • 6.2.1. Global Cancer Biopsy Market by Tissue Biopsies , 2018–2028(USD Billion)
    • 6.3. Liquid Biopsies
      • 6.3.1. Global Cancer Biopsy Market by Liquid Biopsies, 2018–2028(USD Billion)
  • Chapter 7. Company Profiles
    • 7.1. Qiagen N.V.
      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product Portfolio
      • 7.1.4. Business Strategy
      • 7.1.5. Recent Developments
    • 7.2. Hulogic, Inc.
      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product Portfolio
      • 7.2.4. Business Strategy
      • 7.2.5. Recent Developments
    • 7.3. Illumina, Inc.
      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product Portfolio
      • 7.3.4. Business Strategy
      • 7.3.5. Recent Development
    • 7.4. Biocept, Inc.
      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product Portfolio
      • 7.4.4. Business Strategy
      • 7.4.5. Recent Development
    • 7.5. ANGLE Plc
      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product Portfolio
      • 7.5.4. Business Strategy
      • 7.5.5. Recent Development
    • 7.6. Danaher Corporation
      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product Portfolio
      • 7.6.4. Business Strategy
      • 7.6.5. Recent Development
    • 7.7. Roche Hulding AG
      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product Portfolio
      • 7.7.4. Business Strategy
      • 7.7.5. Recent Development
    • 7.8. GRAIL, Inc.
      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product Portfolio
      • 7.8.4. Business Strategy
      • 7.8.5. Recent Development
    • 7.9. Freenome Huldings, Inc.
      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product Portfolio
      • 7.9.4. Business Strategy
      • 7.9.5. Recent Development
    • 7.10. Lucence Diagnostics Private Limited
      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product Portfolio
      • 7.10.4. Business Strategy
      • 7.10.5. Recent Development
    • 7.11. Epigenomics AG
      • 7.11.1. Overview
      • 7.11.2. Financials
      • 7.11.3. Product Portfolio
      • 7.11.4. Business Strategy
      • 7.11.5. Recent Development
    • 7.12. HelioHealth
      • 7.12.1. Overview
      • 7.12.2. Financials
      • 7.12.3. Product Portfolio
      • 7.12.4. Business Strategy
      • 7.12.5. Recent Development
    • 7.13. Genesystems, Inc.
      • 7.13.1. Overview
      • 7.13.2. Financials
      • 7.13.3. Product Portfolio
      • 7.13.4. Business Strategy
      • 7.13.5. Recent Development
    • 7.14. Natera, Inc.
      • 7.14.1. Overview
      • 7.14.2. Financials
      • 7.14.3. Product Portfolio
      • 7.14.4. Business Strategy
      • 7.14.5. Recent Development
    • 7.15. Chronix Biomedical, Inc.
      • 7.15.1. Overview
      • 7.15.2. Financials
      • 7.15.3. Product Portfolio
      • 7.15.4. Business Strategy
      • 7.15.5. Recent Development
    • 7.16. Personal Genome Diagnostics Inc.
      • 7.16.1. Overview
      • 7.16.2. Financials
      • 7.16.3. Product Portfolio
      • 7.16.4. Business Strategy
      • 7.16.5. Recent Development
    • 7.17. Personalis, Inc.
      • 7.17.1. Overview
      • 7.17.2. Financials
      • 7.17.3. Product Portfolio
      • 7.17.4. Business Strategy
      • 7.17.5. Recent Development
    • 7.18. Biodesix
      • 7.18.1. Overview
      • 7.18.2. Financials
      • 7.18.3. Product Portfolio
      • 7.18.4. Business Strategy
      • 7.18.5. Recent Development

List of Figures

1. Market research Type
2. Market research methodology
3. Global Cancer Biopsy Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Cancer Biopsy Marketattractiveness, By Product
6. Global Cancer Biopsy Marketattractiveness, By Type
7. Global Cancer Biopsy Marketshare by Product ,2020 and 2028 (USD Billion)
8. Global Cancer Biopsy Marketby Kits & Consumables, 2018–2028(USD Billion)
9. Global Cancer Biopsy Marketby Instruments, 2018–2028(USD Billion)
10. Global Cancer Biopsy Marketshare by Type ,2020 and 2028 (USD Billion)
11. Global Cancer Biopsy Marketby Tissue Biopsies , 2018–2028(USD Billion)
12. Global Cancer Biopsy Marketby Liquid Biopsies, 2018–2028(USD Billion)
13. Global Cancer Biopsy Marketshare, by Region, 2020 and 2028
14. North America Cancer Biopsy Market, 2018–2028(USD Billion)
15. Europe Cancer Biopsy Market, 2018–2028(USD Billion)
16. Asia Pacific Cancer Biopsy Market, 2018–2028(USD Billion)
17. Latin America Cancer Biopsy Market, 2018–2028(USD Billion)
18. The Middle East and Africa Cancer Biopsy Market, 2018–2028(USD Billion)
 


List of Tables

1. Global Cancer Biopsy Market: snapshot
2. Drivers of the Cancer Biopsy Market: impact analysis
3. North America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
4. North America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
5. The U.S. Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
6. The U.S. Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
7. Rest of North America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
8. Rest of North America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
9. Europe Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
10. Europe Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
11. UK Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
12. UK Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
13. France Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
14. France Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
15. Germany Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
16. Germany Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
17. Rest of Europe Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
18. Rest of Europe Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
19. Asia Pacific Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
20. Asia Pacific Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
21. China Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
22. China Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
23. Japan Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
24. Japan Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
25. India Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
26. India Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
27. Rest of Asia Pacific Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
28. Rest of Asia Pacific Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
29. Latin America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
30. Latin America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
31. Brazil Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
32. Brazil Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
33. Rest of Latin America Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
34. Rest of Latin  America Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
35. The Middle East and Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
36. The Middle East and Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
37. Saudi Arabia Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
38. Saudi Arabia Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
39. South Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
40. South Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)
41. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Product  ,2018–2028(USD Billion)
42. Rest of the Middle East & Africa Cancer Biopsy Market revenue, By Type  ,2018–2028(USD Billion)

 
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

Massive application of liquid biopsy and breakthroughs in biopsy methods are slated to steer expansion of cancer biopsy market over forthcoming years. In addition to this, minimal invasive nature of deriving circulating tumor cells has made biopsy as most popular tool in detecting various kinds of cancer in patients. Apparently, introduction of new techniques such as next-generation sequencing will embellish industry space in upcoming years. Furthermore, a prominent role played by image-driven needle biopsies in domain of precision medicine will proliferate size of cancer biopsy market over ensuing years.

Moreover, surging molecular assays is key to expansion of cancer biopsy industry. Additionally, in clinical studies, biopsies are also utilized for identifying drug response rate for patients receiving epidermal growth factor receptor treatments. This will further drive market trends. Apart from this, increase in number of medical trials in biomarker research activities will expand cancer biopsy market size. 

According to Zion market research report, the global cancer biopsy market accrued earnings worth approximately 22.3(USD Billion) in 2020 and is predicted to gain revenue of about 47.5(USD Billion) by 2028, is set to record a CAGR of nearly 11.1% over the period from 2021 to 2028.

North America will contribute lucratively towards the global market size over the estimated timeline. The regional market surge is due to prominent surge in number of diagnostic kit manufacturers & distributors in the sub-continent. Rise in acceptance of liquid biopsies in the U.S. will create lucrative growth avenues for cancer biopsy industry in North America during assessment period.    

The key market participants include Qiagen N.V., Hologic, Inc., Illumina, Inc., Biocept, Inc., ANGLE Plc, Danaher Corporation, Roche Holding AG, GRAIL, Inc., Freenome Holdings, Inc., Lucence Diagnostics Private Limited, Epigenomics AG, HelioHealth, Genesystems, Inc., Natera, Inc., Chronix Biomedical , Inc., Personal Genome Diagnostics Inc., Personalis Inc., and Biodesix.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social